{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:35:02Z","timestamp":1762421702797,"version":"build-2065373602"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T00:00:00Z","timestamp":1635292800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006254","name":"Ruhr-Universit\u00e4t Bochum","doi-asserted-by":"publisher","award":["F978-2020"],"award-info":[{"award-number":["F978-2020"]}],"id":[{"id":"10.13039\/501100006254","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Methods & Clinical Development"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.omtm.2021.10.009","type":"journal-article","created":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T20:01:44Z","timestamp":1635451304000},"page":"539-550","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Quantification of cell-free DNA for the analysis of CD19-CAR-T cells during lymphoma treatment"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3790-5826","authenticated-orcid":false,"given":"Thomas","family":"Mika","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Thomson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Verena","family":"Nilius-Eliliwi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4175-5683","authenticated-orcid":false,"given":"Deepak","family":"Vangala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Baraniskin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerald","family":"Wulf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne","family":"Klein-Scory","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland","family":"Schroers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2021.10.009_bib1","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1056\/NEJMoa1707447","article-title":"Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma","volume":"377","author":"Neelapu","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2021.10.009_bib2","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1056\/NEJMoa1407222","article-title":"Chimeric antigen receptor T\u00a0cells for sustained remissions in leukemia","volume":"371","author":"Maude","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2021.10.009_bib3","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1172\/JCI126397","article-title":"B cell maturation antigen-specific CAR T\u00a0cells are clinically active in multiple myeloma","volume":"129","author":"Cohen","year":"2019","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omtm.2021.10.009_bib4","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1056\/NEJMoa1817226","article-title":"Anti-BCMA CAR T-cell therapy bb2121 in relapsed or refractory multiple myeloma","volume":"380","author":"Raje","year":"2019","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2021.10.009_bib5","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1056\/NEJMoa1709919","article-title":"Long-term follow-up of CD19 CAR therapy in acute lymphoblastic leukemia","volume":"378","author":"Park","year":"2018","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2021.10.009_bib6","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1056\/NEJMoa1804980","article-title":"Tisagenlecleucel in adult relapsed or refractory diffuse large B-cell lymphoma","volume":"380","author":"Schuster","year":"2019","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2021.10.009_bib7","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1182\/blood-2018-11-887067","article-title":"The response to lymphodepletion impacts PFS in patients with aggressive non-Hodgkin lymphoma treated with CD19 CAR T\u00a0cells","volume":"133","author":"Hirayama","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2021.10.009_bib8","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41591-018-0010-1","article-title":"Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T\u00a0cell therapy of chronic lymphocytic leukemia","volume":"24","author":"Fraietta","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.omtm.2021.10.009_bib9","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1182\/blood-2011-10-384388","article-title":"B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T\u00a0cells","volume":"119","author":"Kochenderfer","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2021.10.009_bib10","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3389\/fmolb.2020.00084","article-title":"Digital-droplet PCR for quantification of CD19-directed CAR T-cells","volume":"7","author":"Mika","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.omtm.2021.10.009_bib11","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.3390\/cancers12071970","article-title":"Accurate in-vivo quantification of CD19 CAR-T cells after treatment with axicabtagene ciloleucel (Axi-Cel) and tisagenlecleucel (Tisa-Cel) using digital PCR","volume":"12,","author":"Badbaran","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.omtm.2021.10.009_bib12","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/ijlh.13073","article-title":"Digital droplet PCR-based chimerism analysis for monitoring of hematopoietic engraftment after allogeneic stem cell transplantation","volume":"41","author":"Mika","year":"2019","journal-title":"Int. J. Lab. Hematol."},{"key":"10.1016\/j.omtm.2021.10.009_bib13","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jmoldx.2019.08.007","article-title":"Comparison of real-time quantitative PCR and digital droplet PCR for BCR-ABL1 monitoring in patients with chronic myeloid leukemia","volume":"22","author":"Franke","year":"2020","journal-title":"J.\u00a0Mol. Diagn."},{"key":"10.1016\/j.omtm.2021.10.009_bib14","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1007\/s00277-018-3451-1","article-title":"A comparison of qPCR and ddPCR used for quantification of the JAK2 V617F allele burden in Ph negative MPNs","volume":"97","author":"Link-Lenczowska","year":"2018","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.omtm.2021.10.009_bib15","doi-asserted-by":"crossref","first-page":"17884","DOI":"10.1038\/s41598-020-74927-8","article-title":"Quantitative PCR methodology with a volume-based unit for the sophisticated cellular kinetic evaluation of chimeric antigen receptor T\u00a0cells","volume":"10","author":"Yamamoto","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtm.2021.10.009_bib16","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1208\/s12248-021-00560-6","article-title":"Insights on droplet digital PCR-based cellular kinetics and biodistribution assay support for CAR-T cell therapy","volume":"23","author":"Sugimoto","year":"2021","journal-title":"AAPS J."},{"key":"10.1016\/j.omtm.2021.10.009_bib17","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.3389\/fonc.2020.01115","article-title":"Evolution of RAS mutational status in liquid biopsies during first-line chemotherapy for metastatic colorectal cancer","volume":"10","author":"Klein-Scory","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.omtm.2021.10.009_bib18","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.tranon.2017.12.010","article-title":"Significance of liquid biopsy for monitoring and therapy decision of colorectal cancer","volume":"11","author":"Klein-Scory","year":"2018","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.omtm.2021.10.009_bib19","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/cas.13450","article-title":"Clinical significance of disease-specific MYD88 mutations in circulating DNA in primary central nervous system lymphoma","volume":"109","author":"Hattori","year":"2018","journal-title":"Cancer Sci."},{"key":"10.1016\/j.omtm.2021.10.009_bib20","doi-asserted-by":"crossref","first-page":"eaat4921","DOI":"10.1126\/scitranslmed.aat4921","article-title":"Enhanced detection of circulating tumor DNA by fragment size analysis","volume":"10","author":"Mouliere","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtm.2021.10.009_bib21","doi-asserted-by":"crossref","first-page":"648","DOI":"10.3324\/haematol.2018.206177","article-title":"Liquid biopsy in lymphoma","volume":"104","author":"Rossi","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.omtm.2021.10.009_bib22","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/sj.gt.3302270","article-title":"Pois(s)on--it's a question of dose","volume":"11","author":"Fehse","year":"2004","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2021.10.009_bib23","doi-asserted-by":"crossref","first-page":"568056","DOI":"10.3389\/fonc.2020.568056","article-title":"Altered T-lymphocyte biology following high-dose melphalan and autologous stem cell transplantation with implications for adoptive T-cell therapy","volume":"10","author":"Mika","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.omtm.2021.10.009_bib24","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.bbmt.2018.12.758","article-title":"ASTCT consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells","volume":"25","author":"Lee","year":"2019","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.omtm.2021.10.009_bib25","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S1470-2045(15)70106-3","article-title":"Circulating tumour DNA and CT monitoring in patients with untreated diffuse large B-cell lymphoma: a correlative biomarker study","volume":"16","author":"Roschewski","year":"2015","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.omtm.2021.10.009_bib26","doi-asserted-by":"crossref","first-page":"107830","DOI":"10.1016\/j.celrep.2020.107830","article-title":"Senescence, necrosis, and apoptosis govern circulating cell-free DNA release kinetics","volume":"31","author":"Rostami","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.omtm.2021.10.009_bib27","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.mrrev.2006.11.002","article-title":"Circulating free DNA in plasma or serum as biomarker of carcinogenesis: practical aspects and biological significance","volume":"635","author":"Gormally","year":"2007","journal-title":"Mutat. Res."},{"key":"10.1016\/j.omtm.2021.10.009_bib28","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.3390\/ijms20061283","article-title":"Killing mechanisms of chimeric antigen receptor (CAR) T\u00a0cells","volume":"20","author":"Benmebarek","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtm.2021.10.009_bib29","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/cgt.2013.35","article-title":"Combining CAR T\u00a0cells and the Bcl-2 family apoptosis inhibitor ABT-737 for treating B-cell malignancy","volume":"20","author":"Karlsson","year":"2013","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.omtm.2021.10.009_bib30","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/hon.2704","article-title":"The development of liquid biopsy for research and clinical practice in lymphomas: report of the 15-ICML workshop on ctDNA","volume":"38","author":"Rossi","year":"2020","journal-title":"Hematol. Oncol."},{"key":"10.1016\/j.omtm.2021.10.009_bib31","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1373\/clinchem.2007.101030","article-title":"Cell-free plasma DNA as a predictor of outcome in severe sepsis and septic shock","volume":"54","author":"Saukkonen","year":"2008","journal-title":"Clin. Chem."},{"key":"10.1016\/j.omtm.2021.10.009_bib32","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0009-8981(02)00337-6","article-title":"Elevated cell-free serum DNA detected in patients with myocardial infarction","volume":"327","author":"Chang","year":"2003","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.omtm.2021.10.009_bib33","first-page":"362","article-title":"Bench-to-bedside translation of chimeric antigen receptor (CAR) T\u00a0cells using a multiscale systems pharmacokinetic-pharmacodynamic model: a case study with anti-BCMA CAR-T. CPT Pharmacometrics Syst","volume":"10","author":"Singh","year":"2021","journal-title":"Pharmacol"},{"key":"10.1016\/j.omtm.2021.10.009_bib34","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/978-1-4939-9151-8_9","article-title":"MRD detection in B-cell non-Hodgkin lymphomas using Ig gene rearrangements and chromosomal translocations as targets for real-time quantitative PCR","volume":"1956","author":"Pott","year":"2019","journal-title":"Methods Mol. Biol. (Clifton, N.J.)"},{"key":"10.1016\/j.omtm.2021.10.009_bib35","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41586-018-0178-z","article-title":"Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T\u00a0cells","volume":"558","author":"Fraietta","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2021.10.009_bib36","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/s41467-019-13880-1","article-title":"Clonal kinetics and single-cell transcriptional profiling of CAR-T cells in patients undergoing CD19 CAR-T immunotherapy","volume":"11","author":"Sheih","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtm.2021.10.009_bib37","article-title":"Molecular imaging of chimeric antigen receptor T\u00a0cells by ICOS-ImmunoPET","author":"Simonetta","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.omtm.2021.10.009_bib38","doi-asserted-by":"crossref","first-page":"FSO295","DOI":"10.4155\/fsoa-2017-0140","article-title":"Kinetics of circulating cell-free DNA for biomedical applications: critical appraisal of the literature","volume":"4","author":"Khier","year":"2018","journal-title":"Future Sci. OA"},{"key":"10.1016\/j.omtm.2021.10.009_bib39","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.jmoldx.2015.05.007","article-title":"Minimal residual disease detection by droplet digital PCR in multiple myeloma, mantle cell lymphoma, and follicular lymphoma: a comparison with real-time PCR","volume":"17","author":"Drandi","year":"2015","journal-title":"J.\u00a0Mol. Diagn."},{"key":"10.1016\/j.omtm.2021.10.009_bib40","first-page":"S49","article-title":"Limit of blank, limit of detection and limit of quantitation","volume":"29","author":"Armbruster","year":"2008","journal-title":"Clin. Biochem. Rev."}],"container-title":["Molecular Therapy - Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050121001662?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050121001662?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:30:14Z","timestamp":1762421414000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050121001662"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":40,"alternative-id":["S2329050121001662"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2021.10.009","relation":{},"ISSN":["2329-0501"],"issn-type":[{"type":"print","value":"2329-0501"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantification of cell-free DNA for the analysis of CD19-CAR-T cells during lymphoma treatment","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2021.10.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s).","name":"copyright","label":"Copyright"}]}}